article thumbnail

Article EMA Thank You Updated EUDAMED roadmap projects mandatory use of some processes as early as December 2025

Agency IQ

Updated EUDAMED roadmap projects mandatory use of some processes as early as December 2025 The new EUDAMED roadmap includes updates accounting for the recent amendments to the European medical device and diagnostics regulations, which allow for a phased rollout of the different functional modules of the database.

article thumbnail

Inside the Altascientist: Considerations for Safe and Compliant HPAPI Manufacturing

Alta Sciences

billion by 2029. Manufacturing these drug products involves expert specialization and careful consideration to ensure that GMP regulations for drug submissions are met, the risk of exposure for CDMO-related personnel is reduced, and every effort is made to prevent cross-contamination.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Article EMA Thank You Proposal for IVDR extension also impacts MDR, EUDAMED

Agency IQ

regulators considered the highest-risk IVD devices, and these and devices for self-test by the patient required Notified Body oversight. The IVDR originally gave stakeholders 5 years to comply with the regulation (May 26, 2022). The directive used a list-based system – List A and List B outlined what E.U. Once the E.U.

article thumbnail

CMS Finalizes Guidance on Medicare Part D Manufacturer Discount Program

FDA Law Blog: Biosimilars

Each phase-in policy allows eligible manufacturers to build up in a stepwise manner to the 10% and 20% applicable discounts by 2029 and 2031, respectively. CMS also intends to implement a compliance monitoring program through future regulations or guidance. had Part D expenditures on or before August 16, 2022).

article thumbnail

Analysis Chemical Thank You ECHA issues research wish list to aid in its regulatory endeavors

Agency IQ

Its latest report serves as a powerful indicator for what EU chemical regulation is likely to resemble in the coming years should the agency receive sufficient scientific support to meet four regulatory challenges ECHA just can’t solve without further progress from the scientific community.

article thumbnail

Analysis Chemical Thank You How states are looking to control PFAS through different legislative models

Agency IQ

By 2029, this will include artificial turf as well as outdoor apparel for severe weather conditions (unless it is accompanied by a specific warning statement). States like Alaska and North Carolina are taking a more surgical approach in regulating PFAS based on these bills, targeting well-known exposures from AFFFs or from food packaging.

article thumbnail

Genomics/Biobanks/Cohort Studies

Broad Institute

Known to be a regulator of metabolism, we have found that in addition it has profound behavioral effects in animals and humans, even evident in population-level economic behavior. The Sabatini Lab focuses on the development and regulation of synapses in the brain and the relationship of these processes to behavior and disease.